中华老年心脑血管病杂志

参考文献

[1]Studnek JR,Bentley M,Crawford JM,et al.An assessment of key health indicators among emergency medical services professionals.Prehosp Emerg Care,2010,14:14-20.

[2]Broderick JP,Palesch YY,Demchuk AM,et al.Endovascular therapy after intravenous t-PA versus t-PA alone for stroke.N Engl J Med,2013,368:893-903.

[3]Meretoja A,Keshtkaran M,Saver JL,et al.Stroke thrombolysis:save a minute,save a day.Stroke,2014,45:1053-1058.

[4]中国脑卒中医疗治疗评估协作组.中国急性缺血性脑卒中治疗现状.中华神经科杂志,2009,42:223-227.

[5]Wang Y,Liao X,Zhao X,et al.Using recombinant tissue plasminogen activator to treat acute ischemic stroke in China:analysis of the results from the Chinese National Stroke Registry(CNSR).Stroke,2011,42:1658-1664.

[6]赵颖,辛秀峰,徐安定,等.关键医疗质量指标监控对提高缺血性脑血管病临床医疗质量的作用.暨南大学学报,2013,34:186-190.

[7]Fonarow GC,Reeves MJ,Smith EE,et al.Characteristics,performance measures,and in-hospital outcomes of the first one million stroke and transient ischemic attack admissions in get with the guidelines-stroke.Circ Cardiovasc Qual Outcomes,2010,3:291-302.

[8]王伊龙,吴敌,周勇,等.中国七城市卒中患者急诊溶栓情况分析.中国卒中杂志,2009,4:23-28.

[9]黄小钦,贾建平,刘丽旭,等.早期就诊的急性缺血性卒中病人未溶栓原因分析.脑与神经疾病杂志,2007,15:346-348.

[10]Smith EE,Fonarow GC,Reeves MJ,et al.Outcomes in mild or rapidly improving stroke not treated with intravenous recombinant tissue-type plasminogen activator:finding from Get With The Guideline-Stroke.Stroke,2011,42:3110-3115.

[11]Leira EC,Ludwig BR,Gurol ME,et al.The type of neurological deficits might not justify withholding treatment in patients with low total National Institutes of Health Stroke Scale scores.Stroke,2012,43:782-786.

[12]Stecksén A,Asplund K,Appelros P,et al.Thrombolytic therapy rates and stroke severity:an analysis of date from the Swedish stroke register(Riks-Stroke)2007-2010.Stroke,2012,43:536-538.

[13]Fonarow GC,Smith EE,Saver JL,et al.Timelines of tissuetype plasminogen activator therapy in acute ischemic stroke:patient characteristics,hospital factors,and outcomes associated with door-to-needle times with 60 minutes.Circulation,2011,123:750-758.

[14]Meretoja A,Strbian D,Mustanoja S,et al.Reducing in-hospital delay to 20 minutes in stroke thrombosis.Neurology,2012,79:306-313.

[15]Meretoja A,Weir L,Ugalde M,et al.Helsinki model cut stroke thrombosis delays to 25minutes in Melbourne in only4months.Neurology,2013,81:1071-1076.

[16]Ford AL,Williams JA,Spencer M,et al.Reducing door-toneedle times using Toyota's lean manufacturing principles and value stream analysis.Stroke,2012,43:3395-3398.

[17]Coote S,Frost T,Singhal S,et al.Direct to CT:overcoming barriers to reduce door to needle time in acute stroke patients.Stroke,2014,45:AWP177.

[18]Mishra NK,Ahmed N,Andersen G,et al.Thrombolysis in very elderly people:controlled comparison of SITS International Stroke Thrombosis Registry and Virtual International Stroke Trials Archive.BMJ,2010,341:c6046.

[19]IST-3collaborative group,Sandercock P,Wardlaw JM,et al.The benefits and harms of intravenous thrombosis with recombinant tissue plasminogen activator within 6hof acute ischemic stroke(the third International Stroke Trial[IST-3]):a randomized controlled trial.Lancet,2012,379:2352-2363.